A new study published in the journal of CNS Drugs showed that low-dose naltrexone (LDN) did not outperform placebo in ...

The NCNED is preparing to launch two clinical trials, one for long COVID and another for ME/CFS, testing the effectiveness of low-dose Naltrexone. This drug, typically used for opioid addiction ...

He was prescribed low dose naltrexone early into the course of his illness and 12 months on, is back to about 70 per cent of ...

Based on the existing data, a low-dose, continuous i.v. infusion of naloxone ... with the keywords naloxone, naltrexone, pruritus, and opioid antagonist. The search was limited to English-language ...